As of Oct 20
| -0.01 / -0.94%|
The 5 analysts offering 12-month price forecasts for Novavax Inc have a median target of 1.50, with a high estimate of 2.00 and a low estimate of 1.10. The median estimate represents a +42.86% increase from the last price of 1.05.
The current consensus among 7 polled investment analysts is to Hold stock in Novavax Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.